Inventor

CARR MARIA GRAZIA

GB21 patents

⚠️ This page may combine multiple inventors who share the name “CARR MARIA GRAZIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CARR MARIA GRAZIA

ASTEX THERAPEUTICS LTD

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Benzimidazole derivatives and their use as protein kinase inhibitors

Dihydroxyphenyl isoindolymethanones

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Hydroxybenzamide derivatives and their use as inhibitors of HSP90

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pharmaceutical compounds

BERDINI VALERIO

Bicyclic heterocyclic compounds as FGFR inhibitors

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

Imidazo[1,2-a]pyridine compounds for use in treating cancer

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

CHESSARI GIANNI

Dihydroxyphenyl isoindolylmethanones

Hydroxybenzamide derivatives and their use as inhibitors of HSP90

Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90

SAXTY GORDON

FGFR pharmacophore compounds

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors